Cough is a sudden expulsion of air through breathing passage that helps to clear mucous or fluids, foreign particles, and microbes. It is a protective reflex action and can be repetitive. Frequent coughing indicates presence of any irritation or disease. Choking, smoking, air pollution, asthama, bacterial infection, chronic bronchitis, lung tumors, and others can be the causes of cough. Cough can be divided into acute cough and chronic cough. Cough suppressants inhibit coughing and irritation in throat. Dextromethorphan, salbutamol, inhaled corticosteroids, and benzonatate are the some drugs which can be used as cough suppressants.
COVID-19 Impact Analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the cough suppressant drugs market.
Top Impacting Factors
- Increase in prevalence of cough all over the globe, surge in adoption of unhealthy lifestyle, rise in consumption of cigarettes, increase in cases of respiratory tract infection, rise in high risk due to exposure to pollens, and surge in geriatric population are the key factors that drive the growth of the market.
- In addition, surge in adoption of highly advance cough suppressant drugs, emerging advance technology in developing countries, R&D activities to improve quality of drugs, launch of novel drugs, rise in infrastructure developments through government funding, and aggressive development strategies by key market players are expected to boost the growth of the market.
- However, side effects related to cough suppressant drugs and stringent regulation for over the counter medicines hinder the growth of the market.
- Contrarily, increase in demand of cost effective treatment and government support for fast track regulatory approvals are expected to offer lucrative opportunities for the expansion of the market.
Market Trends
New Product Launches to Flourish the Market
In 2021, Ernest Chemists announced launch of new herbal cough remedy named as Honeykof. This product use in treatment of throat infection and reduce amount of cough.
In 2018, Perrigo Company Plc, announced FDA approval for launch of its OTC brand Mucinex DM Maximum Strength. This product use to reduce repetitive cough and break up mucus.
Key Benefits of the Report
- This study presents the analytical depiction of cough suppressant drugs market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Cough Suppressant Drugs Market Report
- Which are the leading players active in the cough suppressant drugs market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is "cough suppressant drugs"?
- What is "cough suppressant drugs" market prediction in the future?
- Who are the leading global players in the "cough suppressant" market?
- What are the current trends and predicted trends?
- What are the key benefits of the "cough suppressant drugs" market report?
Cough Suppressant Drugs Market, by Indication Report Highlights
| Aspects | Details |
 By Indication |
|
 By Drug Type |
|
 By Dosage Form |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Acella Pharmaceuticals LLC, Perrigo Company plc, Vernalis plc,, Mayne Pharma Inc., GlaxoSmithKline plc., Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd, Pfizer Inc., Aytu BioScience, Inc., Taro Pharmaceutical Industries Ltd. |
Loading Table Of Content...
